Explore the shift in COPD management toward disease activity and GETomics. Learn how the GOLD 2026 report emphasizes early intervention and therapeutic targets.

We’ve moved into an era where we treat 'disease activity' as a formal therapeutic target. It’s like how we treat rheumatoid arthritis—we don’t just wait for the joints to hurt; we look for modifiable biological activity to slow down the actual destruction.
Teaching on management of assessment, investigations, diagnosis and management of COPD








The GOLD 2026 report marks a major shift by establishing disease activity as a formal therapeutic target in COPD management. Rather than simply reacting to symptoms like breathlessness, clinicians are encouraged to treat the underlying biological activity to slow lung destruction. This approach mirrors treatments for conditions like rheumatoid arthritis, focusing on suppressing the disease before irreversible structural damage occurs, making the traditional wait-and-see method obsolete.
GETomics represents a modern era in respiratory health that examines the complex interaction between a person's genes, their environment, and their lifetime trajectory. This framework helps healthcare providers understand how these factors combine to damage the lungs over time. By utilizing GETomics, the medical community can better identify how disease activity manifests and progresses, allowing for more personalized and proactive management strategies for patients at risk of or living with COPD.
Early intervention is critical because structural issues like small-airway disease and emphysema often appear on CT scans years before a patient fails a spirometry test. By the time symptoms are obvious, significant lung damage may have already occurred. Modern management focuses on catching these changes early to prevent irreversible damage. This proactive strategy aims to address modifiable biological activity early in the disease trajectory to improve long-term patient outcomes.
Treating disease activity as a therapeutic target means focusing on the active biological processes causing lung damage rather than just managing symptoms with inhalers. This shift involves looking for modifiable markers of destruction and intervening to suppress them. The goal is to prevent the 'fire' of the disease from causing permanent harm to the respiratory system, moving away from reactive care toward a model that prioritizes the preservation of lung function through early detection.
From Columbia University alumni built in San Francisco
"Instead of endless scrolling, I just hit play on BeFreed. It saves me so much time."
"I never knew where to start with nonfiction—BeFreed’s book lists turned into podcasts gave me a clear path."
"Perfect balance between learning and entertainment. Finished ‘Thinking, Fast and Slow’ on my commute this week."
"Crazy how much I learned while walking the dog. BeFreed = small habits → big gains."
"Reading used to feel like a chore. Now it’s just part of my lifestyle."
"Feels effortless compared to reading. I’ve finished 6 books this month already."
"BeFreed turned my guilty doomscrolling into something that feels productive and inspiring."
"BeFreed turned my commute into learning time. 20-min podcasts are perfect for finishing books I never had time for."
"BeFreed replaced my podcast queue. Imagine Spotify for books — that’s it. 🙌"
"It is great for me to learn something from the book without reading it."
"The themed book list podcasts help me connect ideas across authors—like a guided audio journey."
"Makes me feel smarter every time before going to work"
From Columbia University alumni built in San Francisco
